4 – Alzheimers

The U.S. Food and Drug Administration (FDA) Peripheral and Central Nervous System Drugs Advisory Committee did not recommend approval of florbetapir (Amyvid, Lilly/Avid) injection for imaging amyloid plaques based on the currently available data. At the same time, the committee did vote to recommend approval of florbetapir conditional on development ... continue reading

There will be a free educational and informative seminar on Alzheimer’s Wednesday evening at Parkland Health Center in Farmington. The free program will be held in the hospital dining room from 6 to 8 p.m., and will be hosted by the Lead Belt Memory Walk Committee and the St. Louis ... continue reading